Bradykinin antagonists: new opportunities

被引：50

作者：

Bock, MG ^{[1
]}

Longmore, J

机构：

[1] Merck Res Labs, W Point, PA 19486 USA

[2] Merck Sharp & Dohme Ltd, Res Labs, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England

来源：

CURRENT OPINION IN CHEMICAL BIOLOGY | 2000年 / 4卷 / 04期

关键词：

D O I：

10.1016/S1367-5931(00)00107-1

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The pro-inflammatory, pain producing, and cardiovascular effects of bradykinin B-2 receptor activation are well characterized. Bradykinin B-1 receptors also produce inflammation and pain. Therefore, antagonists are expected to be anti-inflammatory/analgesic drugs. Other exploitable clinical opportunities may exist. The newly discovered non-peptide B-2 receptor antagonists and the equivalent B-1 receptor pharmacological agents, which are in the pipeline, are suitable preclinical tools to properly evaluate potential utilities.

引用

页码：401 / 406

页数：6

共 37 条

[21] Small molecule antagonists of the bradykinin B1 receptor [J].

Horlick, RA ;

Ohlmeyer, MH ;

Stroke, IL ;

Strohl, B ;

Pan, GH ;

Schilling, AE ;

Paradkar, V ;

Quintero, JG ;

You, M ;

Riviello, C ;

Thorn, MB ;

Damaj, B ;

Fitzpatrick, VD ;

Dolle, RE ;

Webb, ML ;

Baldwin, JJ ;

Sigal, NH .

IMMUNOPHARMACOLOGY, 1999, 43 (2-3) :169-177

[22]

Kayakiri Hiroshi, 1999, Drugs of the Future, V24, P629, DOI 10.1358/dof.1999.024.06.545142

[23]

LEE YJ, 2000, LIFE SCI, V307, P94

[24] Role of the bradykinin B2 receptor in the maturation of blood pressure phenotype, lesson from transgenic and knockout mice [J].

Madeddu, P ;

Emanueli, C ;

Gaspa, L ;

Salis, B ;

Milia, AF ;

Chao, L ;

Chao, J .

IMMUNOPHARMACOLOGY, 1999, 44 (1-2) :9-13

[25] KININ B-1 RECEPTORS - A REVIEW [J].

MARCEAU, F .

IMMUNOPHARMACOLOGY, 1995, 30 (01) :1-26

[26]

Meini S, 1999, J PHARMACOL EXP THER, V289, P1250

[27] Acetylillustrol: A new compound from Mandevilla illustris (Vell.) Woodson (Apocynaceae) [J].

Niero, R ;

Calixto, JB ;

Filho, JDDS ;

Yunes, RA ;

Sant'ana, AEG .

NATURAL PRODUCT LETTERS, 1999, 13 (01) :63-70

[28] Bradykinin B1 receptor expression and function on T lymphocytes in active multiple sclerosis [J].

Prat, A ;

Weinrib, L ;

Becher, B ;

Poirier, J ;

Duquette, P ;

Couture, R ;

Antel, JP .

NEUROLOGY, 1999, 53 (09) :2087-2092

[29] In vitro and in vivo effects of the new nonpeptide bradykinin B2 receptor antagonist, LF 16-0335C, on guinea-pig and rat kinin receptors [J].

Pruneau, D ;

Luccarini, JM ;

Fouchet, C ;

Defrêne, E ;

Franck, RM ;

Loillier, B ;

Duclos, H ;

Robert, C ;

Cremers, B ;

Bélichard, P ;

Paquet, JL .

FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1999, 13 (01) :75-83

[30]

PRUNEAU D, 1998, 15 INT C KIN 1998 OC

← 1 2 3 4 →